View in EDS HTML Full Text PDF Full Text

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Saved in:
Bibliographic Details
Title: Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.
Authors: Caronna, Edoardo1,2 (AUTHOR), Mas-de-les-Valls, Rut2 (AUTHOR), Egeo, Gabriella3 (AUTHOR), Vázquez, Manuel Millán4 (AUTHOR), Castellanos, Candela Nieves5 (AUTHOR), Membrilla, Javier A.6,7 (AUTHOR), Vaghi, Gloria8,9 (AUTHOR), Rodríguez-Montolio, Joana10,11 (AUTHOR), Fabra, Neus Fabregat12 (AUTHOR), Caballero, Francisco Sánchez13 (AUTHOR), Jaimes, Alex14 (AUTHOR), Muñoz-Vendrell, Albert15 (AUTHOR), Oliveira, Renato16 (AUTHOR), Gárate, Gabriel17 (AUTHOR), Osorio, Yesica González18 (AUTHOR), Guisado-Alonso, Daniel19 (AUTHOR), Ornello, Raffaele20 (AUTHOR), Thunstedt, Cem21 (AUTHOR), Fernández-Lázaro, Iris22 (AUTHOR), Sánchez-Soblechero, Antonio23 (AUTHOR)
Source: Cephalalgia. Jun2026, Vol. 46 Issue 6, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03331024
DOI:10.1177/03331024261440370